Notícias

Massachusetts has filed a lawsuit against UnitedHealth Group, alleging the company exaggerated illness severity for Medicaid patients to obtain higher payments. The case focuses on claimed inflation of patient risk scores within the state’s Medicaid program and UnitedHealth has denied any wrongdoing. The lawsuit introduces additional legal and reputational questions for UnitedHealth Group that go beyond routine operational updates. UnitedHealth Group (NYSE:UNH) is facing this legal...

Download the Complete Report Here REX American Resources Corp. (REX) 45Z and Lower Corn Costs Drive Record First Quarter; One Earth and CCS Projects Advance; Valuation Remains Reasonable Key Takeaways: REX delivered its best first-quarter EPS of $0.56, well ahead of consensus at $0.14 and up from $0.26 y/y. 45Z is becoming a structural earnings […]

While Lockheed Martin has considerably underperformed the Dow recently, analysts remain moderately optimistic about the stock’s prospects.

In the most recent trading session, Delta Air Lines (DAL) closed at $81.47, indicating a -1.22% shift from the previous trading day.

Alphabet plans an $80 billion AI equity raise with Berkshire Hathaway committing a $10 billion anchor investment.

Dow Jones Futures: Broadcom, Micron, Nvidia and Sandisk were big winners Monday. Credo plunged on earnings late.

BlackRock has considerably underperformed the Nasdaq recently, yet analysts remain highly optimistic about the stock’s prospects.

Anthropic has filed for an IPO and Strategy finally sold bitcoin for the first time since 2022.

Credo Technology stock declines despite better-than-expected earnings. The stock has rallied 157% since bottoming at the end of March.

Top cryptocurrencies were mixed on Monday, with Bitcoin (BTC-USD) falling below the $72,000 level.

Strategy sold 32 bitcoin between May 26 and May 31 at an average price of $77,135. Proceeds will fund distributions on its preferred stock. The news pushed bitcoin under $72,000. CoinDesk's Sam Ewen hosts "CoinDesk Daily."

Although the stock is still up more than 10% year to date, it has fallen by just as much from a year ago.

Some shareholders are selling shares of the nuclear energy giant. You should probably buy instead. Here's why.

Most home-building stocks have been weak in the past year, with Taylor Morrison trading near a 52-week low on Friday.

The bitcoin-hoarding firm founded by Michael Saylor sold 32 coins last week for $2.5 million to fund distributions on its preferred stock

Seagate agreed to pay $175 million to settle claims that it failed to disclose hard drive sales to Huawei that allegedly violated U.S. export restrictions.

Rocket Lab Selloff Deepens as High-Flying Space Stocks Lose Altitude

Strategy sold 32 BTC (~$2.5M) to help fund preferred stock dividend payments. The sale represented just 0.004% of its 843,706 BTC holdings and was made ...

The bitcoin-hoarding firm says it sold the cryptocurrency to fund distributions on its preferred stock.

Strategy sold about $2.5 million of Bitcoin as investors questioned its long-standing hold strategy.

Despite Vertex Pharmaceuticals' underperformance relative to the healthcare sector over the past year, Wall Street analysts remain strongly optimistic about the stock’s prospects.

(Updates prices.) Gold fell off a two-week high midafternoon Monday as the dollar rose after fres

The market was disappointed by the more detailed data on a landmark trial for the company's multi-cancer early detection (MCED) test.

A resurgence in software stocks is carrying the S&P 500 and Nasdaq to fresh highs despite the latest Iran war worries. The Nasdaq was up 0.5%, while the S&P 500 was up 0.2%. The Dow was down 102 points, or 0.2%.

Photronics' Q2 FY26 EPS and revenue miss estimates as IC revenues fall on delayed chip design releases; gross margin shrinks, and Q3 guidance remains cautious.

Although the stock is still up more than 10% year to date, it has fallen by just as much from a year ago.

Above Food Ingredients disclosed a Nasdaq delisting notice tied to its failure to file audited financial statements and Form 20-F.

SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) was one of the stocks on Jim Cramer’s radar on Mad Money as he explained that many investors might be missing out on the market’s biggest winners. Responding to a caller’s question about the company, Cramer stated: Oh, this life science company that is, look, okay, so this is […]

Jefferies gives mixed messages on Redwire today, as investors sell the space stock.

Jefferies noted that Redwire and space-related stocks have seen significant momentum so far this year, driven by the buzz surrounding SpaceX’s planned public listing.